Regulatory Affairs Outsourcing Market Revenue To Witness Rapid Growth In Near Future : Fact.MR

The global regulatory affairs outsourcing market is anticipated to secure a market value of US$ 15.11 Bn by 2032 while expanding at a CAGR of 8% during the forecast period from 2022 to 2032. The rising number of product registrations and the growing clinical trial applications are key factors propelling the market growth. In addition, the rapid development of the biotechnology and pharmaceutical industry is projected to hold significant opportunities for market expansion in the forthcoming period.

The growing pressure on personal pockets and the initiatives taken by various governments in the concerned field are likely to provide thrust to the industry's growth. Also, the growing demand to reduce costs in the life-science sector is likely to create a significant demand for third-party services for regulatory affairs. In addition, the increasing application of efficacious software to keep a record of regulatory affairs is expected to augment the market size during the forecast period.

For critical insights on this market, request for More Info - https://www.factmr.com/connectus/sample?flag=S&rep_id=7143

The outbreak of the COVID-19 pandemic posed a major challenge across the globe which resulted in emergency usage of various equipment approved by FDA and EU, which boosted the market significantly during the lockdown period. Moreover, development of critical vaccines and drugs to counter the coronavirus threat has further widened prospects for the market.

Key Market Segments Covered in the Global Regulatory Affairs Outsourcing Market

By Services
Regulatory Consulting Outsourcing
Legal Representation Outsourcing
Regulatory Writing & Publishing Outsourcing
Other Regulatory Affairs Outsourcing Services

By Company Size
Regulatory Affairs Outsourcing for Small Sized Companies
Regulatory Affairs Outsourcing for Medium Sized Companies
Regulatory Affairs Outsourcing for Large Sized Companies

By Category
Regulatory Affairs Outsourcing for Drugs
Generics
Innovators
Regulatory Affairs Outsourcing for Biologics
Biotech
ATMPs
Biosimilars
Regulatory Affairs Outsourcing for Medical Devices
Therapeutic
Diagnostic

By Indication
Regulatory Affairs Outsourcing for Oncology
Regulatory Affairs Outsourcing for Neurology
Regulatory Affairs Outsourcing for Radiology
Regulatory Affairs Outsourcing for Immunology
Regulatory Affairs Outsourcing for Other Indications

By Stage
Pre-Clinical Regulatory Affairs Outsourcing
Clinical Regulatory Affairs Outsourcing
Post Market Authorization Regulatory Affairs Outsourcing

By End Use
Regulatory Affairs Outsourcing for Medical Device Companies
Regulatory Affairs Outsourcing for Pharmaceutical Companies
Regulatory Affairs Outsourcing for Biotechnology Companies

Request more information about Report Methodology - https://www.factmr.com/connectus/sample?flag=RM&rep_id=7143

Key Takeaways from the Market Study

The global regulatory affairs outsourcing market to value US$ 7 Bn in 2022

From 2015-2021, regulatory affairs outsourcing demand flourished at a 6.5% CAGR

APAC to garner a market share of 37% in 2022 with respect to regulatory affairs outsourcing

Clinical studies segment procured the largest market share of 46% in 2021.

Based on end-user segment, the pharmaceutical companies segment to secure the largest market share of 38% in 2022.

Competitive Landscape

Key players of the global regulatory affairs outsourcing market take various initiatives to strengthen their influence across the globe and secure the forefront position in the market. Some recent developments among key players:

In July 2021, PRA Health Sciences, a CRO, was acquired by ICON. The company aims to bring together 38,000 employees across 47 countries and create the most advanced healthcare infrastructure and clinical research organization.
In August 2021, ProPharma Group, disclosed its acquisition of iSafety, which is an Indian pharmacovigilance outsourcing service provider.

For in-depth competitive analysis, Buy Now - https://www.factmr.com/checkout/7143

More Valuable Insights

Fact.MR, in its new offering, presents an unbiased analysis of the global regulatory affairs outsourcing market, presenting historical market data (2015-2021) and forecast statistics for the period of 2022-2032.

The study reveals essential insights based on services (product registration & clinical trial applications, legal representation, regulatory consulting, regulatory writing & publishing and other services), category (biologics, drugs and medical devices), company size (small sized companies, medium sized companies and large sized companies), indication (immunology, neurology, cardiology, oncology and others), stage (pre-clinical, clinical and PMA (post market authorization)) and end use (medical device companies, pharmaceutical companies and biotechnology companies) across five major regions (North America, MEA, Latin America, Europe and Asia Pacific).

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email : sales@factmr.com
Website : https://www.factmr.com

About Us:
Market research and consulting agency with a difference! That's why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range - from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analysed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we'll be an able research partner.

This release was published on openPR.